CoverageAustralia · Checked · Rechecked monthly
Mounjaro on the PBS: Is It Listed and What It Costs
As of 20 November 2026, Mounjaro is not on the PBS, either for weight loss or for type 2 diabetes. You pay the private price: A$270 to A$689 a pen, depending on your dose.
Is Mounjaro on the PBS?
No. The PBS does not subsidise Mounjaro for any use.
Weight lossNo PBS submission made
Type 2 diabetesRecommended Mar 2026, listing process ceased
Private price per penA$270 – A$689
Based on the PBS medicine status pages and PBAC advice. This page is updated when the status changes.
What you pay depends on your dose.
See the price of each Mounjaro dose in AustraliaThe price runs from A$270 – $285 at 2.5 mg to A$665 – $689 at 12.5 mg and A$665 – $689 at 15 mg.
PBS statusListing dateMedicarePricePBS chargesDiscountsInsuranceStepsFAQ
Mounjaro PBS
The Pharmaceutical Benefits Scheme (PBS) is how the Australian Government pays most of the cost of a medicine. Once a medicine is listed, you pay only a set patient charge.
Mounjaro is not on the PBS. It is registered in Australia for weight management, but the PBS does not subsidise it.
The PBS names only two GLP-1 medicines listed for type 2 diabetes: Ozempic (semaglutide) and Trulicity (dulaglutide). Mounjaro is not one of them.
For the same question about Wegovy, see Wegovy on the PBS.
When will Mounjaro be listed on the PBS
For weight loss, there is nothing to wait for yet. The PBS says the maker, Eli Lilly, has not made a submission to list tirzepatide for obesity, so the PBAC has not considered it as an obesity treatment.
Type 2 diabetes has a longer history. The PBAC did not recommend a listing in November 2024, and it deferred a decision in July 2025.
Mounjaro type 2 diabetes listing, from the PBS medicine status pages (current at 1 November 2026)
November 2024Not recommended
July 2025Decision deferred
11 March 2026Recommended for adults with inadequately controlled type 2 diabetes
NowLilly is not proceeding at this time, process ceased
A PBAC recommendation does not put a drug on the PBS by itself. The maker has to carry on with the listing process, and Lilly has said it is not doing so now. No date exists.
Do not plan your treatment around a PBS price. Until an official date appears, the private price is the one to budget for.
Mounjaro Medicare
Your Medicare card does not lower the price of Mounjaro. That is because the drug is not on the PBS.
Medicare can still apply to the doctor visit where you get the prescription. It does not apply to the pen.
Ozempic is different. It is on the PBS for type 2 diabetes, and its rules are in Ozempic on the PBS.
Mounjaro price in Australia
With no PBS price, each pharmacy sets its own. A public price list for online prescription uploads in November 2026 showed A$270 to A$689 for one KwikPen.
Mounjaro KwikPen price, private prescription, November 2026
2.5 mgA$270 – $285
5 mgA$375 – $425
7.5 mgA$530 – $549
10 mgA$530 – $549
12.5 mgA$665 – $689
15 mgA$665 – $689
The price climbs with the dose, from A$270 – $285 at 2.5 mg to A$665 – $689 at 15 mg.
Lowest dose, 2.5 mgA$270 – $2857.5 mg or 10 mgA$530 – $549Top doses, 12.5 mg or 15 mgA$665 – $689
That is one public price list. Your price can differ with the pharmacy, stock, how you get the prescription, and any consultation or delivery fee. The steps between doses are in Mounjaro dosing chart.
What you spend over a year depends on how long you stay on each dose.
Work out what your treatment will costTo compare countries, see Mounjaro price in the UK.
PBS patient charges in 2026
When a medicine is on the PBS, you pay a set charge. From 1 January 2026 the general patient charge is A$25 for most PBS medicines, and A$7.70 with a concession card.
PBS patient charges and Safety Net thresholds from 1 January 2026
General patient chargeA$25
Concession card chargeA$7.70
General Safety Net thresholdA$1,748.20
Concession Safety Net thresholdA$277.20
These charges apply only to PBS-listed medicines. They do not apply to Mounjaro today.
Mounjaro discounts
No manufacturer discount programme for Mounjaro in Australia turned up in public sources. The US savings card works for US prescriptions only, and its rules are in Mounjaro coupon in the US.
Two things lower what you pay: ask two or three pharmacies for the same dose, and compare the total with any consultation and delivery fee added.
Mounjaro cost with insurance
In Australia there is no government subsidy for Mounjaro, so the private prices above are what you pay.
Whether a private health fund pays anything toward the pen depends on the product, and no single national rule applies. Ask your fund about your own policy.
The UK works differently: the NHS covers Mounjaro for some patients. See Mounjaro on the NHS.
How to get Mounjaro at the lowest price you can
1Get a prescriptionAn Australian-registered prescriber writes it after a live consultation by video, phone or in person.
2Compare pharmacy pricesAsk for the same dose at two or three pharmacies, with consultation and delivery fees included.
3Watch the PBS status pageIf Mounjaro is ever listed, ask your prescriber whether you meet the listing rules.
Your prescriber decides when to change your dose.
Mounjaro PBS FAQ
Is Mounjaro on the PBS?
No. As of 20 November 2026, Mounjaro is not on the PBS for any use.
Does Medicare cover Mounjaro?
No. Your Medicare card does not lower the price of the pen. It can apply to the consultation.
How much does Mounjaro cost in Australia?
A$270 to A$689 a pen: A$270 – $285 for 2.5 mg, A$375 – $425 for 5 mg, A$530 – $549 for 7.5 mg, A$530 – $549 for 10 mg, A$665 – $689 for 12.5 mg, and A$665 – $689 for 15 mg.
Is there a Mounjaro discount in Australia?
No manufacturer discount has been published for Australia. Prices differ by pharmacy, so comparing is the main way to save.
When will Mounjaro be on the PBS?
There is no date. No application exists for weight loss, and for type 2 diabetes Lilly stopped the process after the PBAC recommendation.
Is there a generic Mounjaro in Australia?
The current position is in Mounjaro generic name.
Keep reading
Mounjaro cost in Australia: price by dose
Wegovy on the PBS in Australia
Ozempic on the PBS: who qualifies
What Mounjaro is and how it works
GLP1 Note rechecks the PBS status and prices on this page every month against the PBS and PBAC pages. It is updated as soon as the status changes. See how we check prices.
Update log
: First published.
Sources
Pharmaceutical Benefits Scheme, Medicine status: Tirzepatide (Mounjaro), type 2 diabetes.
Pharmaceutical Benefits Scheme, Medicine status: Tirzepatide (Mounjaro), November 2024 submission.
Pharmaceutical Benefits Scheme, PBAC advice on equitable access to GLP-1 obesity treatments.
Pharmaceutical Benefits Scheme, Current patient fees and charges.
GLP1 Note is an independent information site and does not sell medicines. Prices and listing status can change, so check the PBS page before you rely on them.